SCHEMBL6568667

SCHEMBL6568667

CC(C)(C)NC(=O)Nc1cc(CC(=O)NCCc2ccccc2)cc(Cl)c1O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 7/20 0.56
CA2 P00918 7/20 0.56
HSD17B2 P37059 2/20 0.56
NPC1 O15118 4/20 0.54
RAB9A P51151 4/20 0.54
MAPT P10636 1/20 0.54
HPGD P15428 3/20 0.47
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
ALDH1A1 P00352 2/20 0.47
GLA P06280 1/20 0.44
MAPK1 P28482 1/20 0.42
LTA4H P09960 1/20 0.42
EPHX2 P34913 1/20 0.42
GAA P10253 2/20 0.41
ESRRB O95718 1/20 0.41
ESRRG P62508 1/20 0.41
CA12 O43570 1/20 0.41
CA9 Q16790 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6521859 0.84 NPC1 (0.58) CA1CA2NPC1RAB9AMAPT
SCHEMBL6567548 0.82 CA1 (0.75) CA1CA2HSD17B2NPC1RAB9A
SCHEMBL6522452 0.79 ALDH1A1 (0.48) NPC1RAB9AMAPTHPGDMEN1
SCHEMBL4345315 0.75 CNR1 (0.59) CA1CA2HSD17B2NPC1RAB9A
SCHEMBL6251887 0.74 NPC1 (0.46) CA1CA2NPC1RAB9AMAPT
SCHEMBL7375328 0.72 NPC1 (1.00) CA1CA2NPC1RAB9AMAPT
SCHEMBL6567257 0.71 NPC1 (0.41) CA1CA2NPC1MAPTHPGD
SCHEMBL4347164 0.70 KMT2A (0.53) CA1CA2NPC1RAB9AMAPT
SCHEMBL4341271 0.70 NPC1 (0.52) CA1CA2HSD17B2NPC1RAB9A
SCHEMBL4360010 0.70 SMN1; SMN2 (0.64) CA1CA2NPC1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1402887-A1 New compounds for the inhibition of undesired cell proliferation and use thereof Jerini AG (DE) 2004-03-31 EP claimed
EP-1402888-A1 The use of substituted carbocyclic compounds as rotamases inhibitors Jerini AG (DE) 2004-03-31 EP claimed